Scene And Heard At BIO – From The IN VIVO Blog
This article was originally published in The Pink Sheet Daily
Executive Summary
Vaccine applications to FDA are booming; Vertex outgoing CEO Josh Boger on the vision of George Merck; Merck-Serono portfolio guru Vince Aurentz; a review of meeting swag, and more from Day 3 in Atlanta.